Potential of Various Drugs to Inhibit Nucleoside Uptake in Rat Syncytiotrophoblast Cell Line, TR-TBT 18d-1

T. Chishu, Y. Sai, Tomohiro Nishimura, K. Sato, N. Kose, E. Nakashima

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The placenta requires nucleosides as nutrients for fetal growth, so it is important to examine potential interactions between placental transports of nucleosides and drugs to ensure the safety of pharmacotherapy during pregnancy. The purposes of this study are to clarify the uptake mechanisms of nucleosides from the maternal side of the syncytiotrophoblast and to investigate the inhibitory effect of various drugs on nucleoside uptake, using the rat syncytiotrophoblast cell line TR-TBT 18d-1, which shows syncytial-like morphology and functional expression of several transporters. Initial uptake of [3H]uridine or [3H]adenosine from the apical side of TR-TBT 18d-1 was markedly reduced by an excess of the respective unlabelled compound, and was slightly reduced by replacement of Na+ with N-methyl-d-glucamine, indicating that both uptakes were Na+-independent. [3H]Uridine and [3H]adenosine uptakes in the absence of Na+ were significantly and concentration-dependently inhibited by both 0.1 μM and 100 μM nitrobenzylthioinosine, suggesting the involvement of equilibrative nucleoside transporters (ENTs, SLC29). Kinetic analysis of adenosine uptake yielded a Km value of approximately 17 μM. These results are consistent with the reported uptake characteristics of uridine and adenosine by ENT1 and ENT2. The uptakes were significantly reduced by high concentrations of several nucleoside drugs, including cytarabine, vidarabine, zidovudine, mizoribine, caffeine and amitriptyline, but the effects were small within the therapeutic concentration ranges. In summary, our results suggest that ENTs are involved in apical uptake of uridine and adenosine in the syncytiotrophoblast. However, therapeutic concentrations of the drugs tested in this study might have little influence on maternal-to-fetal nucleoside transfer.

Original languageEnglish
Pages (from-to)461-467
Number of pages7
JournalPlacenta
Volume29
Issue number5
DOIs
Publication statusPublished - 2008 May

Fingerprint

Trophoblasts
Nucleosides
Adenosine
Uridine
Cell Line
Pharmaceutical Preparations
Mothers
Nucleoside Transport Proteins
Vidarabine
Amitriptyline
Zidovudine
Cytarabine
Fetal Development
Caffeine
Placenta
Safety
Drug Therapy
Food
Pregnancy
Therapeutics

Keywords

  • Adenosine
  • Drug interaction
  • Nucleoside
  • Placental barrier
  • Transport
  • Trophoblast
  • Uridine

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Potential of Various Drugs to Inhibit Nucleoside Uptake in Rat Syncytiotrophoblast Cell Line, TR-TBT 18d-1. / Chishu, T.; Sai, Y.; Nishimura, Tomohiro; Sato, K.; Kose, N.; Nakashima, E.

In: Placenta, Vol. 29, No. 5, 05.2008, p. 461-467.

Research output: Contribution to journalArticle

Chishu, T. ; Sai, Y. ; Nishimura, Tomohiro ; Sato, K. ; Kose, N. ; Nakashima, E. / Potential of Various Drugs to Inhibit Nucleoside Uptake in Rat Syncytiotrophoblast Cell Line, TR-TBT 18d-1. In: Placenta. 2008 ; Vol. 29, No. 5. pp. 461-467.
@article{91f7b8b5750a4f3995d48ac3f9a242da,
title = "Potential of Various Drugs to Inhibit Nucleoside Uptake in Rat Syncytiotrophoblast Cell Line, TR-TBT 18d-1",
abstract = "The placenta requires nucleosides as nutrients for fetal growth, so it is important to examine potential interactions between placental transports of nucleosides and drugs to ensure the safety of pharmacotherapy during pregnancy. The purposes of this study are to clarify the uptake mechanisms of nucleosides from the maternal side of the syncytiotrophoblast and to investigate the inhibitory effect of various drugs on nucleoside uptake, using the rat syncytiotrophoblast cell line TR-TBT 18d-1, which shows syncytial-like morphology and functional expression of several transporters. Initial uptake of [3H]uridine or [3H]adenosine from the apical side of TR-TBT 18d-1 was markedly reduced by an excess of the respective unlabelled compound, and was slightly reduced by replacement of Na+ with N-methyl-d-glucamine, indicating that both uptakes were Na+-independent. [3H]Uridine and [3H]adenosine uptakes in the absence of Na+ were significantly and concentration-dependently inhibited by both 0.1 μM and 100 μM nitrobenzylthioinosine, suggesting the involvement of equilibrative nucleoside transporters (ENTs, SLC29). Kinetic analysis of adenosine uptake yielded a Km value of approximately 17 μM. These results are consistent with the reported uptake characteristics of uridine and adenosine by ENT1 and ENT2. The uptakes were significantly reduced by high concentrations of several nucleoside drugs, including cytarabine, vidarabine, zidovudine, mizoribine, caffeine and amitriptyline, but the effects were small within the therapeutic concentration ranges. In summary, our results suggest that ENTs are involved in apical uptake of uridine and adenosine in the syncytiotrophoblast. However, therapeutic concentrations of the drugs tested in this study might have little influence on maternal-to-fetal nucleoside transfer.",
keywords = "Adenosine, Drug interaction, Nucleoside, Placental barrier, Transport, Trophoblast, Uridine",
author = "T. Chishu and Y. Sai and Tomohiro Nishimura and K. Sato and N. Kose and E. Nakashima",
year = "2008",
month = "5",
doi = "10.1016/j.placenta.2008.01.010",
language = "English",
volume = "29",
pages = "461--467",
journal = "Placenta",
issn = "0143-4004",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Potential of Various Drugs to Inhibit Nucleoside Uptake in Rat Syncytiotrophoblast Cell Line, TR-TBT 18d-1

AU - Chishu, T.

AU - Sai, Y.

AU - Nishimura, Tomohiro

AU - Sato, K.

AU - Kose, N.

AU - Nakashima, E.

PY - 2008/5

Y1 - 2008/5

N2 - The placenta requires nucleosides as nutrients for fetal growth, so it is important to examine potential interactions between placental transports of nucleosides and drugs to ensure the safety of pharmacotherapy during pregnancy. The purposes of this study are to clarify the uptake mechanisms of nucleosides from the maternal side of the syncytiotrophoblast and to investigate the inhibitory effect of various drugs on nucleoside uptake, using the rat syncytiotrophoblast cell line TR-TBT 18d-1, which shows syncytial-like morphology and functional expression of several transporters. Initial uptake of [3H]uridine or [3H]adenosine from the apical side of TR-TBT 18d-1 was markedly reduced by an excess of the respective unlabelled compound, and was slightly reduced by replacement of Na+ with N-methyl-d-glucamine, indicating that both uptakes were Na+-independent. [3H]Uridine and [3H]adenosine uptakes in the absence of Na+ were significantly and concentration-dependently inhibited by both 0.1 μM and 100 μM nitrobenzylthioinosine, suggesting the involvement of equilibrative nucleoside transporters (ENTs, SLC29). Kinetic analysis of adenosine uptake yielded a Km value of approximately 17 μM. These results are consistent with the reported uptake characteristics of uridine and adenosine by ENT1 and ENT2. The uptakes were significantly reduced by high concentrations of several nucleoside drugs, including cytarabine, vidarabine, zidovudine, mizoribine, caffeine and amitriptyline, but the effects were small within the therapeutic concentration ranges. In summary, our results suggest that ENTs are involved in apical uptake of uridine and adenosine in the syncytiotrophoblast. However, therapeutic concentrations of the drugs tested in this study might have little influence on maternal-to-fetal nucleoside transfer.

AB - The placenta requires nucleosides as nutrients for fetal growth, so it is important to examine potential interactions between placental transports of nucleosides and drugs to ensure the safety of pharmacotherapy during pregnancy. The purposes of this study are to clarify the uptake mechanisms of nucleosides from the maternal side of the syncytiotrophoblast and to investigate the inhibitory effect of various drugs on nucleoside uptake, using the rat syncytiotrophoblast cell line TR-TBT 18d-1, which shows syncytial-like morphology and functional expression of several transporters. Initial uptake of [3H]uridine or [3H]adenosine from the apical side of TR-TBT 18d-1 was markedly reduced by an excess of the respective unlabelled compound, and was slightly reduced by replacement of Na+ with N-methyl-d-glucamine, indicating that both uptakes were Na+-independent. [3H]Uridine and [3H]adenosine uptakes in the absence of Na+ were significantly and concentration-dependently inhibited by both 0.1 μM and 100 μM nitrobenzylthioinosine, suggesting the involvement of equilibrative nucleoside transporters (ENTs, SLC29). Kinetic analysis of adenosine uptake yielded a Km value of approximately 17 μM. These results are consistent with the reported uptake characteristics of uridine and adenosine by ENT1 and ENT2. The uptakes were significantly reduced by high concentrations of several nucleoside drugs, including cytarabine, vidarabine, zidovudine, mizoribine, caffeine and amitriptyline, but the effects were small within the therapeutic concentration ranges. In summary, our results suggest that ENTs are involved in apical uptake of uridine and adenosine in the syncytiotrophoblast. However, therapeutic concentrations of the drugs tested in this study might have little influence on maternal-to-fetal nucleoside transfer.

KW - Adenosine

KW - Drug interaction

KW - Nucleoside

KW - Placental barrier

KW - Transport

KW - Trophoblast

KW - Uridine

UR - http://www.scopus.com/inward/record.url?scp=43049106776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43049106776&partnerID=8YFLogxK

U2 - 10.1016/j.placenta.2008.01.010

DO - 10.1016/j.placenta.2008.01.010

M3 - Article

C2 - 18329095

AN - SCOPUS:43049106776

VL - 29

SP - 461

EP - 467

JO - Placenta

JF - Placenta

SN - 0143-4004

IS - 5

ER -